Screening Identification スクリーニング識別の紹介

Discover more insights into Screening Identification スクリーニング識別

Keywords frequently search together with Screening Identification スクリーニング識別

Narrow sentence examples with built-in keyword filters

More Screening Identification スクリーニング識別 sentence examples

10.1007/7355_2019_86

Fluorescent molecular imaging (FMI) has tremendous potential for improving the efficiency of drug screening, evaluating drug effects, accelerating the process, and markedly reducing the cost of new drug development from initial target validation and high-throughput screening identification campaigns to the final human translation phases.

蛍光分子イメージング（FMI）は、薬剤スクリーニングの効率を改善し、薬剤効果を評価し、プロセスを加速し、最初のターゲット検証およびハイスループットスクリーニング識別キャンペーンから最終的な人間の翻訳までの新薬開発のコストを大幅に削減する大きな可能性を秘めています。フェーズ。

Full Text

More Screening Identification スクリーニング識別 sentence examples

10.1007/s00735-019-1010-1

Die häufigsten Risikofaktoren, die durch das Screening Identification of Seniors at Risk (ISAR) vordefiniert wurden, waren Multimedikation, vorangegangene Hospitalisationen, ein vorbestehender Hilfebedarf und eine akute Veränderung des Hilfebedarfs.

リスクのある高齢者のスクリーニング識別（ISAR）によって事前定義された最も一般的な危険因子は、複数の投薬、以前の入院、既存の支援の必要性、および支援の必要性の急激な変化でした。

Full Text

Learn more from Screening Identification スクリーニング識別

Keywords related to Screening

Screening Guide Screening History Screening 2002 Screening Mammogram Screening Ionic Screening Strategy Screening Practices Screening For Screening Decisions Screening Pilot Screening Approach Screening Outreach Screening Beliefs Screening Center Screening Panel Screening Experiences Screening Mri Screening Length Screening Method Screening Behaviors Screening Practice Screening System Screening Cannabinoids Screening Protocol Screening Development Screening Model Screening Device Screening Followed Screening Inventory Screening Und Screening Mechanisms Screening Asymptomatic Screening Applications Screening Drugs Screening Campaigns Screening Improves Screening Urine Screening Round Screening Effectiveness Screening Fitokimia Screening Barriers Screening Characterization Screening Performance Screening Programmes Screening Modality Screening Antimicrobial Screening Selection Screening Experiments Screening Technique Screening Von Explore More

Keywords related to Identification

Facilitate Identification Wireless Identification Phenotype Identification Materials Identification Ligand Identification Mimo Identification Service Identification Remote Identification Isomer Identification Mci Identification Gland Identification Stiffness Identification Material Identification Parametric Identification Pattern Identification Task Identification Numerical Identification Organizational Identification Timely Identification Camera Identification Correct Identification Vessel Identification Rna Identification Fracture Identification Biomarkers Identification Children Identification Part Identification Qtl Identification Structures Identification Blind Identification Function Identification Nonparametric Identification Voice Identification Employee Customer Identification Boundary Identification Frame Identification Conditions Identification Nerve Identification Radiological Identification Proteome Wide Identification Genome Wide Identification Selective Identification Radiofrequency Identification Region Identification Classification Identification Simultaneous Identification Response Identification Strain Identification Patients Identification Mechanism Identification Explore More

Screening Identification スクリーニング識別の概要

Screening Identification スクリーニング識別

Encyclopedia 百科事典

Oct 10, 2024

スクリーニング識別とは何ですか？

Screening Identification スクリーニング識別 - Fluorescent molecular imaging (FMI) has tremendous potential for improving the efficiency of drug screening, evaluating drug effects, accelerating the process, and markedly reducing the cost of new drug development from initial target validation and high-throughput screening identification campaigns to the final human translation phases. ^[1] Die häufigsten Risikofaktoren, die durch das Screening Identification of Seniors at Risk (ISAR) vordefiniert wurden, waren Multimedikation, vorangegangene Hospitalisationen, ein vorbestehender Hilfebedarf und eine akute Veränderung des Hilfebedarfs. ^[2]
蛍光分子イメージング（FMI）は、薬剤スクリーニングの効率を改善し、薬剤効果を評価し、プロセスを加速し、最初のターゲット検証およびハイスループットスクリーニング識別キャンペーンから最終的な人間の翻訳までの新薬開発のコストを大幅に削減する大きな可能性を秘めています。フェーズ。 ^[1] リスクのある高齢者のスクリーニング識別（ISAR）によって事前定義された最も一般的な危険因子は、複数の投薬、以前の入院、既存の支援の必要性、および支援の必要性の急激な変化でした。 ^[2]